| 10.35 Real-Time Quote |  -0.16 / -1.52%Today’s Change | 4.96 Today|||52-Week Range 10.81 | +69.67% Year-to-Date |
| Previous close | 10.51 |
| Today’s open | 10.46 |
| Day’s range | 10.16 - 10.49 |
| Volume | 117,303 |
| Average volume (3 months) | 172,642 |
| Market cap | $386.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -225.00% |
| Earnings growth (this year) | +6.15% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | +1.62% |
| P/E ratio | NM |
| Price/Sales | 3.31 |
| Price/Book | 12.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| VASCVascular Solutions I... | -0.01 | -0.07% |
| RTIXRTI Biologics Inc | -0.11 | -2.50% |
| DSCIDerma Sciences Inc | -0.01 | -0.07% |
| ZLTQZELTIQ Aesthetics In... | +0.08 | +1.26% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.03 |
| Annual revenue (last year) | $63.8M |
| Annual profit (last year) | -$1.8M |
| Net profit margin | -2.76% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Barry G. Caldwell |
Vice President- Global Operations Paul Hambrick |
Corporate headquarters Monrovia, California |
.
